LIPOPOLYSACCHARIDE, TUMOR-NECROSIS-FACTOR, AND INTERLEUKIN-1 INTERACT TO CAUSE HYPOTENSION

被引:0
|
作者
WEINBERG, JR
BOYLE, P
MEAGER, A
GUZ, A
机构
[1] CHARING CROSS & WESTMINSTER MED SCH,DEPT MED,FULHAM PALACE RD,LONDON W6 8RF,ENGLAND
[2] CHARING CROSS & WESTMINSTER MED SCH,DEPT MED MICROBIOL,LONDON W6 8RF,ENGLAND
[3] NATL INST BIOL STAND & CONTROLS,DIV IMMUNOBIOL,S MIMMS,HERTS,ENGLAND
来源
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Lipopolysaccharide (LPS) causes the syndrome of septic shock by initiating the release of endogenous mediators such as tumor necrosis factor (TNF) and interleukin-1 (IL-1) from macrophages. Hypotension is one of the important clinical features of septic shock; however, TNF is only hypotensive in high doses. Therefore we have investigated the interactions of low, nonhypotensive doses of LPS, IL-1, and TNF in the restrained unanesthetized rabbit. Combinations of nonhypotensive doses of TNF, IL-1, and LPS produced significant (p < 0.05) decreases in blood pressure as compared with doses of each of the substances alone. TNF bioactivity in animals that were made hypotensive with combinations of TNF, IL-1, and LPS was lower than in animals that were made hypotensive with TNF alone. This suggests that TNF release that is stimulated by LPS is not the sole cause of the hypotension that is seen in this model of endotoxic shock. In this model, interactions of LPS, IL-1, and TNF occur and may explain hypotension during some episodes of sepsis.
引用
收藏
页码:205 / 211
页数:7
相关论文
共 50 条
  • [31] DIFFERENTIAL INDUCTION OF THE INTERLEUKIN-6 GENE BY TUMOR-NECROSIS-FACTOR AND INTERLEUKIN-1
    NG, SB
    TAN, YH
    GUY, GR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (29) : 19021 - 19027
  • [32] COMPARISON OF PEPTIDOGLYCAN-POLYSACCHARIDE AND LIPOPOLYSACCHARIDE STIMULATION OF KUPFFER CELLS TO PRODUCE TUMOR-NECROSIS-FACTOR AND INTERLEUKIN-1
    LICHTMAN, SN
    WANG, J
    SCHWAB, JH
    LEMASTERS, JJ
    HEPATOLOGY, 1994, 19 (04) : 1013 - 1022
  • [33] CYTOKINE REGULATION OF CORTICOSTEROID RECEPTORS IN THE RAT HIPPOCAMPUS - EFFECTS OF INTERLEUKIN-1, INTERLEUKIN-6, TUMOR-NECROSIS-FACTOR AND LIPOPOLYSACCHARIDE
    BETANCUR, C
    BORRELL, J
    GUAZA, C
    NEUROENDOCRINOLOGY, 1995, 62 (01) : 47 - 54
  • [34] CIRCULATING INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR ANTAGONISTS IN LIVER-DISEASE
    TILG, H
    VOGEL, W
    WIEDERMANN, CJ
    SHAPIRO, L
    HEROLD, M
    JUDMAIER, G
    DINARELLO, CA
    HEPATOLOGY, 1993, 18 (05) : 1132 - 1138
  • [35] NEGATIVE REGULATION OF CYTOKINES - INHIBITION OF THE PRODUCTION OF INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR
    RALPH, P
    NAKOINZ, I
    SAMPSONJOHANNES, A
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1991, 628 : 326 - 336
  • [36] SERUM TUMOR-NECROSIS-FACTOR AND INTERLEUKIN-1 IN LEPROSY AND DURING LEPRA REACTIONS
    PARIDA, SK
    GRAU, GE
    ZAHEER, SA
    MUKHERJEE, R
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 63 (01): : 23 - 27
  • [37] POSSIBLE ROLE OF TUMOR-NECROSIS-FACTOR AND INTERLEUKIN-1 IN THE DEVELOPMENT OF DIABETIC NEPHROPATHY
    HASEGAWA, G
    NAKANO, K
    SAWADA, M
    UNO, K
    SHIBAYAMA, Y
    IENAGA, K
    KONDO, M
    KIDNEY INTERNATIONAL, 1991, 40 (06) : 1007 - 1012
  • [38] TUMOR-NECROSIS-FACTOR AND INTERLEUKIN-1 ENHANCE SLOW-WAVE SLEEP
    KRUEGER, JM
    DINARELLO, CA
    SHOHAM, S
    CADY, AB
    JOURNAL OF LEUKOCYTE BIOLOGY, 1987, 42 (05) : 561 - 561
  • [39] EFFECTS OF INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR ON MEGAKARYOCYTOPOIESIS - MECHANISM OF REACTIVE THROMBOCYTOSIS
    DAN, K
    GOMI, S
    INOKUCHI, K
    OGATA, K
    YAMADA, T
    OHKI, I
    HASEGAWA, S
    NOMURA, T
    ACTA HAEMATOLOGICA, 1995, 93 (2-4) : 67 - 72
  • [40] TUMOR-NECROSIS-FACTOR IS INVOLVED IN THE APPEARANCE OF INTERLEUKIN-1 RECEPTOR ANTAGONIST IN ENDOTOXEMIA
    VANDERPOLL, T
    VANDEVENTER, SJH
    TENCATE, H
    LEVI, M
    TENCATE, JW
    JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (03): : 665 - 667